Thalassaemia Screening among Healthy Blood Donors in Hospital Tengku Ampuan Rahimah, Klang
Thalassaemia Screening in Healthy Blood Donors
Vol. 9 No. 1 : 2014 (44-52)
Abstract
Thalassaemia screening programme has been conducted in Malaysia since 2004. The aim of the programme was to reduce the burden of the disease by identifying thalassaemia carriers. However, the response towards the screening activities was unsatisfactory as there was lack of public awareness against the importance of thalassaemia screening. An alternative approach is to screen blood donors. The purpose of this study was to observe the prevalence of thalassaemia carriers among healthy blood donors. Seven hundred and thirty eight healthy blood donors were screened in Hospital Tengku Ampuan Rahimah, Klang from July to September 2010 using cation-exchange high performance liquid chromatography (HPLC). Cases with haemoglobin variants were further analyzed by gel electrophoresis at alkaline pH. Result shows that the blood donors consisted of 413 Malays (56%), 162 Indians (22%), 148 Chinese (20%) and 15 others (2%). There were 19 (2.6%) individuals with haemoglobin E trait, six (0.8%) with co-inheritance of haemoglobin E and αα-thalassaemia and five (0.7%) with β-thalassaemia trait. Haemoglobin Constant Spring and haemoglobin A2 prime were observed in two (0.3%); and Haemoglobin Lepore and alpha chain variant in one (0.2%). αα-thalassaemia and normal haemoglobin A2 β-thalassaemia could not be excluded in 190 cases (26%), as they required deoxyribonucleic acid (DNA) studies for identification. Thalassaemia screening in blood donors is more feasible and effective. Therefore, a wider scale population screening including blood donors could benefit the existing thalassaemia screening programme in Malaysia.
Keywords :
blood donors,
haemoglobin variants,
Malaysia,
thalassaemia screening,
Correspondance Address
Dr. Ezalia Esa, Haematology Unit, Cancer Research Centre, Institute for Medical Research, Jalan Pahang, 50588 Kuala Lumpur, Malaysia. Tel: +603-26162715 Fax: +603-2616 2566 Email: ezalia@imr.gov.my
References
Ainoon, O., Cheong, S.K. 1994. Thalassaemia in Malaysia: a strategy for prevention. Malays J Pathol 16(1): 23-7.
Al-Arrayed, S., Hafadh, N., Amin, S., Al-Mukhareq, H., Sanad, H. 2003. Student screening for inherited blood disorders in Bahrain. East Mediterr Health J 9(3): 344-52.
AlHamdan, N.A., AlMazrou, Y.Y., AlSwaidi, F.M., Choudhry, A.J. 2007. Premarital screening for thalassaemia and sickle isease in Saudi Arabia. Genet Med 9(6): 372-7.
Anjanna, K., Abdul, Rashid K., Leong, T.X., Atikah, R., Zulhafiz, R. 2011. Awareness Of Thalassaemia Among Rural Folks In Penang, Malaysia. The Internet Journal of Health 12(1).
American Society of Human Genetics Board of Directors, American College of Medical Genetics Board of Directors (ASHG/ACMG). 1995. Points to consider: ethical, legal, and psychosocial implications of genetic testing in children and adolescents. Am J Hum Genet 57(5):1233-41.
Axworthy, D., Brock, D.J., Bobrow, M., Marteau, T.M. 1996. Psychological impact of population-based carrier testing for cystic fibrosis: 3-year follow-up. UK Cystic Fibrosis Follow-Up Study Group. Lancet 347(9013): 1443–6.
Barbara, J.B. 2006. Haemoglobinopathy Diagnosis Second Edition. Oxford: Blackwell Publishing Ltd; 202-3.
Bianco, I., Graziani, B., Lerone, M., Congedo, P., Ponzini, D., Braconi F., Aliquo, C. 1984. A screening programme for the prospective prevention of mediteranean anaemia in latium: results of seven years’ work. J Med Genet 21(4): 268-71.
Boulton, F. 2008. Evidence-based criteria for the care and selection of blood donors, with some comments on the relationship to blood supply, and emphasis on the management of donation-induced iron depletion. Transfus Med 18(1): 13-27.
Bryant, B.J., Hopkins, J.A., Arceo, S.M., Leitman, S.F. 2009. Evaluation of low red blood cell mean corpuscular volume in an apheresis donor population. Transfusion 49(9): 1971-6.
El-Hazmi, M.A. 2009. Ethical issues on prevention and management of blood genetics disorders - Islamic views. Hemoglobin 33(S1): S1-S6.
Frumkin, A., Zlotogora, J. 2008. Genetic screening for reproductive purposes at school: is it a good strategy? Am J Med Genet A 146A(2): 264-269.
George, E. Khuziah, R. 1984. Malays with thalassaemia in West Malaysia. Trop Geogr Med 36(2): 123-5.
George, E. 1998. “Thalassemia: a public health problem in Malaysia,” in Thalassemia Carrier Diagnosis in Malaysia, E. George, Ed., Kuala Lumpur:SP-Muda Printing Sdn Bhd; 1-6.
George, E. 2001. Beta-Thalassemia major in Malaysia, an on-going public health problem. Med J Malaysia 56(4): 397-400.
George, E., Jamal, A.R., Khalid, F., Osman, K.A. 2001. High performance liquid chromatography (HPLC) as a screening tool for classical Beta-thalassaemia trait in Malaysia. Malays J Med Sci 8(2): 40-6.
Hong Kong College of Obstericians and Gynaecologists (HKCOG). 2003. HKCOG Guidelines. Guidelines of Antenatal Thalasaemia Screening. Hong Kong. http://hkcog.obg.cuhk.edu.hk/docs/college_guidelines/Guidelines_of_Antenatal_Thalassaemia_Screening_2003.pdf [25 October 2012].
Joint United Kingdom Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee (JPAC). 2005. Guidelines for the Blood Transfusion Services in the United Kingdom. 7the Edition. United Kingdom: The Stationery Office. http://www.transfusionguidelines.org.uk/red-book [25 October 2012].
Kaplan, E., Zuelzer, WW. 1950. Erythrocyte survival studies in childhood. 2. Studies in Mediterranean anemia. J Lab Clin Med 36(4): 517-23.
Li, X.Y., Lan, J., Luo, R.G., Zhang, T.L., Nong, Q.C., Yang, W.W., Zeng, L.H. Zhang, X.H. 2009. Epidemiological investigation and genotype of thalassaemia on middle school students in Chongzuo, Guangxi. Zhonghua Liu Xing Bing Xue Za Zhi 30(6): 567-70.
Marteau, T.M., van Duijn, M., Ellis I. 1992. Effects of genetic screening on perceptions of health: a pilot study. J Med Genet 29(1): 24–6.
Ministry of Health Malaysia (MOH). 2009. Guidelines on the National Thalassaemia Screening Programme in Malaysia. Division of Family Health Development. Ministry of Health Malaysia; 1-29.
Nadarajan, V.S., Eow, G.I. 2002. Anaemia and iron status among blood donors in a blood transfusion unit in Malaysia. Malays J Pathol 24(2): 99-102.
Newman, B. 1997. Very anaemic donors may pass copper sulphate screening tests. Transfusion 37(6): 670-1.
Northern Ireland Blood Transfusion Services. 2012. Policy Document number POL:10.MP:018:02: http://www.hscbusiness.hscni.net/pdf/Policy_MP018.pdf [1 June 2012]
Rosline, H., Ahmed, S.A., Al-Joudi, F.S., Rapiaah, M., Naing, N.N., Adam, N.A. 2006. Thalassaemia among blood donors at the Hospital Universiti Sains Malaysia. Southeast Asian J Trop Med Public Health 37(3): 549-52.
Ross, L.F. 2006. Heterozygote carrier testing in high schools abroad: What are the lessons for the U.S.? J Law Med Ethics 34(4): 753-64.
Ryan, K, Bain, B.J., Worthington, D., James, J., Plews, D., Mason, A., Roper, D., Rees, D.C., de la Salle, B., Streetly, A., British Committee for Standards in Haematology. 2010. Significant haemoglobinopathies: guidelines for screening and diagnosis. Br J Haematol 149(1): 35-49.
Samavat, A., Modell, B. 2004. Iranian national thalassaemia screening programme. BMJ 329(7475): 1134-7.
Stewart-Brown, S., Farmer, A. 1997. Screening could seriously damage your health. BMJ 314(7080): 533–4.
Troitskaia, O.V., Kuznetsov, V.I., Iushkova, N.M. 1999. Haemoglobinopathies in students at the Russian University of the friendship of peoples. Klin Lab Diagn (5): 19-24,41-6.
Wee, Y.C., Tan, K.L., Chua, K.H., George, E., Tan, J.A. 2009. Molecular characterisation of Haemoglobin Constant Spring and Haemoglobin Quong Sze with a Combine-Amplification Refractory Mutation System. Malays J Med Sci 16(3): 23-30.
Wong, L.P., George, E., Tan, J.A. 2011. Public perceptions and attitudes toward thalassaemia: Influencing factors in a multi-racial population. BMC Public Health 11: 193.
Zlotogora, J. 2009. Population programs for the detection of couples at risk for severe monogenic genetic diseases. Hum Genet 126(2): 247-53.
